Hitachi won Taiwan order on ionic therapy

Hitachi has received a roughly 10 billion yen ($93.8 million) order for an advanced cancer therapy system from a Taiwan hospital, its first overseas sale of heavy-ion therapy.

The Japanese conglomerate announced Wednesday that it won the order from Taipei Veterans General Hospital. Delivery is expected in 2021 or 2022.

The treatment is a type of particle therapy in which carbon ions are accelerated up to 70% of the speed of light and directly targeted at the tumor. The patient experiences little pain during the treatment, and there are few side effects compared with traditional radiation therapy.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s